Literature DB >> 23998423

Immunological perspectives of temporal lobe seizures.

Suvi Liimatainen1, Kai Lehtimäki, Lehtimäki Kai, Johanna Palmio, Palmio Johanna, Tiina Alapirtti, Alapirtti Tiina, Jukka Peltola, Peltola Jukka.   

Abstract

The temporal lobes are affected in many different neurological disorders, such as neurodegenerative diseases, viral and immunological encephalitides, and epilepsy. Both experimental and clinical evidence suggests a different inflammatory response to seizures in patients with temporal lobe epilepsy (TLE) in comparison to those with extra-TLE (XTLE). Proinflammatory cytokines and several autoantibodies have been shown to be associated with TLE compared to other epilepsy types suggesting the specific role and structure of the temporal lobe. Abundant experience suggests that activation of both innate and adaptive immunity is associated with epilepsy, particularly refractory focal epilepsy. Limbic encephalitis often triggers temporal lobe seizures, and a proportion of these disorders are immune-mediated. Histological evidence shows activation of specific inflammatory pathways in resected temporal lobes of epileptic patients, and certain epileptic disorders have shown increased incidence in patients with autoimmune diseases. Rapid activation of proinflammatory cytokines is observed after single seizures, but there is also evidence of chronic overproduction of cytokines and other inflammatory mediators in patients with TLE, suggesting a neuromodulatory role of inflammation in epilepsy. In this review we summarize current data on the presence and the role of immunological factors in temporal lobe seizures, and their possible involvement in epileptogenesis.
© 2013.

Entities:  

Keywords:  Adaptive immunity; Antibody; Cytokine; Innate immunity; Neurodegeneration; Neuromodulation

Mesh:

Substances:

Year:  2013        PMID: 23998423     DOI: 10.1016/j.jneuroim.2013.08.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

Review 2.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.

Authors:  Giovanna Vitaliti; Piero Pavone; Fahad Mahmood; Giuseppe Nunnari; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

Review 3.  Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.

Authors:  Arife Çimen Atalar; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

4.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

5.  Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy.

Authors:  Fei-Ji Sun; Yu-Jia Wei; Song Li; Wei Guo; Xin Chen; Shi-Yong Liu; Jiao-Jiang He; Qing Yin; Hui Yang; Chun-Qing Zhang
Journal:  J Mol Neurosci       Date:  2016-01-21       Impact factor: 3.444

6.  What Elements of the Inflammatory System Are Necessary for Epileptogenesis In Vitro?

Authors:  Kyung-Il Park; Volodymyr Dzhala; Yero Saponjian; Kevin J Staley
Journal:  eNeuro       Date:  2015-03-25

7.  Chronotypes in Patients with Epilepsy: Does the Type of Epilepsy Make a Difference?

Authors:  Hallie Kendis; Kelly Baron; Stephan U Schuele; Bhavita Patel; Hrayr Attarian
Journal:  Behav Neurol       Date:  2015-05-21       Impact factor: 3.342

8.  Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.

Authors:  Kari-Matti Mäkelä; Aki Hietaharju; Antti Brander; Jukka Peltola
Journal:  Front Neurol       Date:  2018-07-13       Impact factor: 4.003

Review 9.  Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Authors:  Robb Wesselingh; Helmut Butzkueven; Katherine Buzzard; David Tarlinton; Terence J O'Brien; Mastura Monif
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

10.  A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy.

Authors:  Pabitra Basnyat; Soila Järvenpää; Jani Raitanen; Marko Pesu; Kai Lehtimäki; Jukka Peltola
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.